跳至主要内容
临床试验/CTRI/2023/02/049832
CTRI/2023/02/049832招募中2/3 期

A Single Arm Clinical Study to evaluate the efficacy of Gojivhadi Malahara in Ahiputana (Napkin Dermatitis) in infants.

Dr Umang Varshney1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2023年1月3日最近更新:

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
38
试验地点
1
主要终点
To decrease kandu(itching) and pidika over perianal region.

研究概览

简要总结

This is a single Arm clinical study in which Gojivhadi Malahara will be provided to 38 patients showing signs and symptoms of Ahiputana (Napkin Dermatitis). The age group taken for the study trial will be infants up to 1 year. The mode of drug administration will be by external application in form of malahara. Patients will be examined on first day and follow up on 3rd & 7th day will be taken. Total duration of drug administration for trial will be of 7 days.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
0.00 Day(s) 至 1.00 Year(s)(—)
性别
All

入选标准

  • Infants who suffer with Ahiputana.
  • Infants age up to 1 year.
  • Patients will be selected irrespective of sex and socioeconomic status.
  • The Patients whose parents are ready to participate in the clinical trial by giving informed written consent.

排除标准

  • Infants having other generalized skin infections.
  • Infants having life threatening illness.
  • Infants who are known case of systemic illness.
  • Infants who have other than clinical signs and symptoms of Ahiputana.
  • Children above 1 year of age.
  • History of Ahiputana more than 10 days.

结局指标

主要结局

To decrease kandu(itching) and pidika over perianal region.

时间窗: 7 days study with follow up on 3rd and 7th day(0,3,7)

次要结局

  • To Observe the adverse effects , if any(7 days study with follow up on 3rd and 7th day(0,3,7))

研究者

发起方
Dr Umang Varshney
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验

Study the effect of Gojivhadi Malahara (Ointment)... | 临床试验